Matches in Wikidata for { <http://www.wikidata.org/entity/Q62513533> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q62513533 description "artículu científicu espublizáu n'agostu de 2002" @default.
- Q62513533 description "im August 2002 veröffentlichter wissenschaftlicher Artikel" @default.
- Q62513533 description "scientific article published on 01 August 2002" @default.
- Q62513533 description "wetenschappelijk artikel" @default.
- Q62513533 description "наукова стаття, опублікована в липні 2002" @default.
- Q62513533 name "Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients" @default.
- Q62513533 name "Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients" @default.
- Q62513533 type Item @default.
- Q62513533 label "Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients" @default.
- Q62513533 label "Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients" @default.
- Q62513533 prefLabel "Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients" @default.
- Q62513533 prefLabel "Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients" @default.
- Q62513533 P1104 Q62513533-D0EE56D8-BE0B-4956-827E-55E4594EE44F @default.
- Q62513533 P1433 Q62513533-31AF87F9-AD2C-43B9-A381-47D51926DEC9 @default.
- Q62513533 P1476 Q62513533-B2C02915-530D-4487-8058-ABE0071E5074 @default.
- Q62513533 P2093 Q62513533-5BCAD6C6-BE8D-4A4E-9F5A-04C7FB306E6D @default.
- Q62513533 P2093 Q62513533-658455A0-9133-4805-B7EA-5014BB2D316A @default.
- Q62513533 P2093 Q62513533-B3DDBD8C-5431-4D2D-AD87-AAC957CE4AF1 @default.
- Q62513533 P2093 Q62513533-F08BC78F-5E03-4566-83D1-DFC7794A72C4 @default.
- Q62513533 P304 Q62513533-2A9DB67C-A812-4346-8A6C-482C8C09052A @default.
- Q62513533 P31 Q62513533-3359CAE3-E1EA-422F-85E2-9BB96FAEB28F @default.
- Q62513533 P356 Q62513533-F909A221-16F9-4F63-A825-12193D511FDB @default.
- Q62513533 P407 Q62513533-4E6AF480-D3F4-42AD-9C0A-91E48896D992 @default.
- Q62513533 P433 Q62513533-1F047F7E-3A52-44B3-AA2F-E6954365346E @default.
- Q62513533 P478 Q62513533-8758022A-8DFE-40FF-95E0-DF56D68AA10D @default.
- Q62513533 P50 Q62513533-87D3F782-5A17-4D11-B363-56B138CEF32B @default.
- Q62513533 P577 Q62513533-EBAED95F-3842-401D-A477-36D9FF87CC75 @default.
- Q62513533 P698 Q62513533-82AB8599-6509-43F7-9BC8-201AA2DB55A0 @default.
- Q62513533 P356 IJC.10524 @default.
- Q62513533 P698 12124808 @default.
- Q62513533 P1104 "+6" @default.
- Q62513533 P1433 Q332492 @default.
- Q62513533 P1476 "Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients" @default.
- Q62513533 P2093 "Hans Grosse-Wilde" @default.
- Q62513533 P2093 "Selma Ugurel" @default.
- Q62513533 P2093 "Uwe Reinhold" @default.
- Q62513533 P2093 "Wolfgang Tilgen" @default.
- Q62513533 P304 "580-585" @default.
- Q62513533 P31 Q13442814 @default.
- Q62513533 P356 "10.1002/IJC.10524" @default.
- Q62513533 P407 Q1860 @default.
- Q62513533 P433 "5" @default.
- Q62513533 P478 "100" @default.
- Q62513533 P50 Q37830567 @default.
- Q62513533 P577 "2002-08-01T00:00:00Z" @default.
- Q62513533 P698 "12124808" @default.